Dec. 13, 2025 at 1:46 PM ET5 min read

CICC Initiates MakeMyTrip with Outperform Rating and $95 Target

Tim BohenAvatar
Written by Tim Bohen
Reviewed by Ben Sturgill Fact-checked by Ellis Hobbs

MakeMyTrip Limited stocks have been trading up by 5.21% amid a surge in travel demand boosting investor confidence.

Market Insights on MakeMyTrip

  • CICC has initiated coverage of MakeMyTrip with an “Outperform” rating, suggesting strong confidence in the company’s future performance.
  • A robust price target of $95 has been set, indicating significant potential upside from current trading levels.
  • This move by CICC reflects positive sentiment around MakeMyTrip’s strategic positioning and growth prospects in the travel sector.

Consumer Discretionary industry expert:

Analyst sentiment – positive

MakeMyTrip (MMYT) is positioned with a current revenue of $978 million, although profitability challenges are evident with a pretax profit margin of -11.8% and negative returns on both assets and equity at -0.01%. The enterprise value of $8.67 billion, coupled with a Price-to-Sales ratio of 8.93, reflects a significant market valuation relative to its sales. The company demonstrates manageable leverage with a long-term debt-to-capital ratio of 0.01, but its retained earnings are deeply negative at ($929.9 million), indicating enduring losses that compromise financial stability. An increase in cash reserves to $508.9 million could provide some cushion, yet overall performance needs revitalization to shift from its current trajectory.

The weekly price pattern for MMYT reveals an ascending trend with consistent price increases over the five-day period, moving from an opening of $69.85 to $82.6. The steady rise in prices suggests a strong bull trend, supported by uniformity in daily closes that highlight absence of intraday volatility. Traders should consider initiating long positions at price pullbacks, targeting a move to breaches past $85, with a stop-loss at $75. Volume consolidation has been noted at higher price levels, supporting further upward momentum in the near term. This market behavior signals robust investor confidence and possible long-term strength.

Recent news indicates an optimistic outlook, with CICC’s coverage initiating an Outperform rating and setting a $95 price target for MMYT. The company’s prospects appear favorable against the robust Consumer Discretionary sector, including the Hotels, Lodging & Leisure benchmarks. Given the positive momentum in equity markets and the observed ascending price trend, it is reasonable to expect MMYT to challenge key resistance near $90. The trading outlook remains bullish with anticipated support solidifying around $80, reflecting a promising trajectory for investors. Overall, the sentiment is decidedly positive, contingent on the company’s ability to enhance its profitability metrics and leverage strategic catalysts.

Candlestick Chart

Weekly Update Dec 08 – Dec 12, 2025: On Saturday, December 13, 2025 MakeMyTrip Limited stock [NASDAQ: MMYT] is trending up by 5.21%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Recent stock trends show an impressive upward trajectory. Over the past few days, the stock moved from $69.85 on December 8th to $82.60 today, marking a noteworthy rise. The company’s solid performance aligns with CICC’s optimistic outlook. Consistently hitting new daily highs reflects strong market interest and confidence.

Financially, MakeMyTrip’s challenges are evident, with a -11.8% pre-tax profit margin, yet its pricing strategy achieves an 8.93 price-to-sales ratio, suggesting investors see value despite hurdles. The strong asset base, with total assets of over $1.8 billion, provides a buffer against financial pressures and points to potential long-term stability.

The latest financial reports reveal significant current assets of over $1 billion, indicating robust liquidity. The company shows a capable workforce with 5,122 employees, suggesting operational readiness for expansion. Despite negative retained earnings, the firm’s additional paid-in capital and total equity suggest resilience in maintaining operational effectiveness.

Conclusion

In summary, MakeMyTrip’s outlook is bullish as reflected by CICC’s recent coverage initiation. The company stands to benefit from growing global travel demand and strategic market positioning. Current financial challenges exist, but robust assets and strategic trader confidence provide a firm platform to build from. As trader confidence aligns with positive market indicators, traders might find potential gains by positioning ahead of anticipated stock movements. As Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” This emphasizes the importance of current trends in trading strategies, aligning with CICC’s actionable insights that make a compelling case for re-evaluating MakeMyTrip’s current and future stock value.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our Algo Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – free of charge